What are common misconceptions trigeminal neuralgia patients have about cannabis?

PostedFebruary 23, 2026

UpdatedFebruary 23, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Cannabis has been increasingly recognised for its potential in managing trigeminal neuralgia, yet many patients still hold misconceptions. Understanding the truth behind cannabis myths about trigeminal neuralgia is crucial for safe and effective use. Misunderstandings can affect treatment adherence and prevent patients from experiencing potential benefits.

Common Misconceptions

Addressing cannabis myths about trigeminal neuralgia helps patients separate fact from fiction and make informed decisions about their care.

Stigma

Some patients fear judgement due to the stigma surrounding cannabis use, believing it is only for recreational purposes rather than medical therapy.

Legality Confusion

Many are unsure about the legal status of cannabis in their region, leading to legality confusion that may prevent them from seeking appropriate medical guidance.

Misuse Concerns

Patients often worry about misuse concerns, assuming cannabis will automatically lead to dependency or harmful side effects, when in reality, responsible, clinician-guided use minimises these risks.

By understanding and addressing cannabis myths about trigeminal neuralgia, patients can approach treatment with clarity and confidence. Dispelling these misconceptions allows better adherence, informed decision-making, and more effective management of trigeminal neuralgia symptoms.

If you’re exploring cannabis treatment options for trigeminal neuralgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and trigeminal neuralgia.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.